Oral Vancomycin Effect in Primary Sclerosing Cholangitis

被引：0
|
作者：
Khan, Ruben [1 ]
Albugeaey, Mohammed [2 ]
Rangnekar, Amol S. [3 ]
机构：
[1] MedStar Georgetown Univ Hosp, Washington, DC USA
[2] MedStar Georgetown Univ Hosp, Dept Gastroenterol, Washington, DC USA
[3] MedStar Georgetown Univ Hosp, Dept Hepatol, Washington, DC USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2015年 / 110卷
关键词：
D O I：
10.14309/00000434-201510001-00911
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
911
引用
收藏
页码：S393 / S393
页数：1
相关论文
共 50 条
  • [21] How frequent are vancomycin-resistant enterococci in patients with primary sclerosing cholangitis and ulcerative colitis treated with oral vancomycin?
    Shah, Ayesha
    Pakneeshan, Sahar
    Jones, Michael P.
    Koloski, Natasha
    Callaghan, Gavin
    Morrison, Mark
    Holtmann, Gerald
    INDIAN JOURNAL OF GASTROENTEROLOGY, 2022, 41 (05) : 519 - 524
  • [22] How frequent are vancomycin-resistant enterococci in patients with primary sclerosing cholangitis and ulcerative colitis treated with oral vancomycin?
    Ayesha Shah
    Sahar Pakneeshan
    Michael P Jones
    Natasha Koloski
    Gavin Callaghan
    Mark Morrison
    Gerald Holtmann
    Indian Journal of Gastroenterology, 2022, 41 : 519 - 524
  • [23] Editorial: vancomycin - a promising option for the treatment of primary sclerosing cholangitis?
    Chapman, R. W.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2018, 47 (09) : 1321 - 1322
  • [24] Reply: Insurance should cover vancomycin for primary sclerosing cholangitis
    Bowlus, Christopher L.
    Arrive, Lionel
    Bergquist, Annika
    Deneau, Mark
    Forman, Lisa
    Ilyas, Sumera I.
    Lunsford, Keri E.
    Martinez, Mercedes
    Sapisochin, Gonzalo
    Shroff, Rachna
    Tabibian, James H.
    Assis, David N.
    HEPATOLOGY, 2023, 77 (06) : E176 - E177
  • [25] TREATMENT OF PRIMARY SCLEROSING CHOLANGITIS WITH ORAL METHOTREXATE
    KNOX, TA
    KAPLAN, MM
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 1991, 86 (05): : 546 - 552
  • [26] Immunomodulatory Effect of Vancomycin on Treg in Pediatric Inflammatory Bowel Disease and Primary Sclerosing Cholangitis
    Abarbanel, David N.
    Seki, Scott M.
    Davies, Yinka
    Marlen, Natalie
    Benavides, Joseph A.
    Cox, Kathleen
    Nadeau, Kari C.
    Cox, Kenneth L.
    JOURNAL OF CLINICAL IMMUNOLOGY, 2013, 33 (02) : 397 - 406
  • [27] Immunomodulatory Effect of Vancomycin on Treg in Pediatric Inflammatory Bowel Disease and Primary Sclerosing Cholangitis
    David N. Abarbanel
    Scott M. Seki
    Yinka Davies
    Natalie Marlen
    Joseph A. Benavides
    Kathleen Cox
    Kari C. Nadeau
    Kenneth L. Cox
    Journal of Clinical Immunology, 2013, 33 : 397 - 406
  • [28] Oral budesonide in the treatment of primary sclerosing cholangitis
    Angulo, P
    Batts, KP
    Jorgensen, RA
    LaRusso, NA
    Lindor, KD
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2000, 95 (09): : 2333 - 2337
  • [29] Oral Vancomycin or Ursodeoxycholic Acid for Pediatric Primary Sclerosing Cholangitis? The Uncontroversial Need for Randomized Controlled Trials
    Assis, David N.
    Levy, Cynthia
    HEPATOLOGY, 2021, 73 (03) : 887 - 889
  • [30] Long-Term Treatment with Oral Vancomycin for the Treatment of Primary Sclerosing Cholangitis and Inflammatory Bowel Disease
    Damman, Jennifer
    Hurwitz, Melissa
    Shah, Shamita
    Davies, Yinka
    Ali, Ahmad Hassan
    Stephan, Mariam
    Lemos, Leta
    Cox, Kenneth L.
    HEPATOLOGY, 2018, 68 : 1091A - 1092A
12345